ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 114 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2024. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $58,490,548 | 25.26% |
| Vivo Capital, LLC | 4,220,048 | $25,446,889 | 2.35% |
| MPM BioImpact LLC | 2,180,864 | $13,150,610 | 2.04% |
| Vestal Point Capital, LP | 3,600,000 | $21,708,000 | 1.62% |
| Redmile Group, LLC | 4,036,451 | $24,339,800 | 1.47% |
| Privium Fund Management B.V. | 396,966 | $2,270,646 | 0.58% |
| Paradigm Biocapital Advisors LP | 1,575,605 | $9,500,898 | 0.36% |
| Nan Fung Group Holdings Ltd | 41,950 | $252,959 | 0.27% |
| Orbimed Advisors | 1,894,462 | $11,423,606 | 0.23% |
| Affinity Asset Advisors, LLC | 100,000 | $603,000 | 0.07% |